These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 38500216

  • 1. iMSC-mediated delivery of ACVR2B-Fc fusion protein reduces heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva.
    Gao P, Inada Y, Hotta A, Sakurai H, Ikeya M.
    Stem Cell Res Ther; 2024 Mar 18; 15(1):83. PubMed ID: 38500216
    [Abstract] [Full Text] [Related]

  • 2. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.
    Barruet E, Morales BM, Lwin W, White MP, Theodoris CV, Kim H, Urrutia A, Wong SA, Srivastava D, Hsiao EC.
    Stem Cell Res Ther; 2016 Aug 17; 7(1):115. PubMed ID: 27530160
    [Abstract] [Full Text] [Related]

  • 3. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1R206H Mouse Model of Fibrodysplasia Ossificans Progressiva.
    Convente MR, Chakkalakal SA, Yang E, Caron RJ, Zhang D, Kambayashi T, Kaplan FS, Shore EM.
    J Bone Miner Res; 2018 Feb 17; 33(2):269-282. PubMed ID: 28986986
    [Abstract] [Full Text] [Related]

  • 4. Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP).
    Wang H, Shore EM, Pignolo RJ, Kaplan FS.
    Bone; 2018 Apr 17; 109():218-224. PubMed ID: 29170109
    [Abstract] [Full Text] [Related]

  • 5. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva.
    Hino K, Ikeya M, Horigome K, Matsumoto Y, Ebise H, Nishio M, Sekiguchi K, Shibata M, Nagata S, Matsuda S, Toguchida J.
    Proc Natl Acad Sci U S A; 2015 Dec 15; 112(50):15438-43. PubMed ID: 26621707
    [Abstract] [Full Text] [Related]

  • 6. BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP).
    Towler OW, Shore EM.
    Dev Dyn; 2022 Jan 15; 251(1):164-177. PubMed ID: 34133058
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification.
    Yamamoto M, Stoessel SJ, Yamamoto S, Goldhamer DJ.
    J Bone Miner Res; 2022 Nov 15; 37(11):2077-2093. PubMed ID: 35637634
    [Abstract] [Full Text] [Related]

  • 8. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva.
    Hino K, Horigome K, Nishio M, Komura S, Nagata S, Zhao C, Jin Y, Kawakami K, Yamada Y, Ohta A, Toguchida J, Ikeya M.
    J Clin Invest; 2017 Sep 01; 127(9):3339-3352. PubMed ID: 28758906
    [Abstract] [Full Text] [Related]

  • 9. Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole-Exome Sequencing in a Patient with Delayed-Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1R206H -Specific Human Cellular and Zebrafish Models.
    Wentworth KL, Lalonde RL, Groppe JC, Brewer N, Moody T, Hansberry S, Taylor KE, Shore EM, Kaplan FS, Pignolo RJ, Yelick PC, Hsiao EC.
    J Bone Miner Res; 2022 Nov 01; 37(11):2058-2076. PubMed ID: 36153796
    [Abstract] [Full Text] [Related]

  • 10. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
    Hino K, Zhao C, Horigome K, Nishio M, Okanishi Y, Nagata S, Komura S, Yamada Y, Toguchida J, Ohta A, Ikeya M.
    Stem Cell Reports; 2018 Nov 13; 11(5):1106-1119. PubMed ID: 30392977
    [Abstract] [Full Text] [Related]

  • 11. The serum levels of activin A and bone morphogenetic protein-4 and -6 in patients with fibrodysplasia ossificans progressiva.
    Ye Z, Wang S, Shan C, Zhu Q, Xue Y, Zhang K.
    Orphanet J Rare Dis; 2023 May 10; 18(1):111. PubMed ID: 37165433
    [Abstract] [Full Text] [Related]

  • 12. The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva.
    Alessi Wolken DM, Idone V, Hatsell SJ, Yu PB, Economides AN.
    Bone; 2018 Apr 10; 109():210-217. PubMed ID: 28629737
    [Abstract] [Full Text] [Related]

  • 13. ACVR1-Fc suppresses BMP signaling and chondro-osseous differentiation in an in vitro model of Fibrodysplasia ossificans progressiva.
    Pang J, Zuo Y, Chen Y, Song L, Zhu Q, Yu J, Shan C, Cai Z, Hao J, Kaplan FS, Shore EM, Zhang K.
    Bone; 2016 Nov 10; 92():29-36. PubMed ID: 27492611
    [Abstract] [Full Text] [Related]

  • 14. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
    Chakkalakal SA, Uchibe K, Convente MR, Zhang D, Economides AN, Kaplan FS, Pacifici M, Iwamoto M, Shore EM.
    J Bone Miner Res; 2016 Sep 10; 31(9):1666-75. PubMed ID: 26896819
    [Abstract] [Full Text] [Related]

  • 15. An anti-ACVR1 antibody exacerbates heterotopic ossification by fibro-adipogenic progenitors in fibrodysplasia ossificans progressiva mice.
    Lees-Shepard JB, Stoessel SJ, Chandler JT, Bouchard K, Bento P, Apuzzo LN, Devarakonda PM, Hunter JW, Goldhamer DJ.
    J Clin Invest; 2022 Jun 15; 132(12):. PubMed ID: 35503416
    [Abstract] [Full Text] [Related]

  • 16. Spatial patterns of heterotopic ossification in fibrodysplasia ossificans progressiva correlate with anatomic temperature gradients.
    Wang H, De Cunto CL, Pignolo RJ, Kaplan FS.
    Bone; 2021 Aug 15; 149():115978. PubMed ID: 33915334
    [Abstract] [Full Text] [Related]

  • 17. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
    van Dinther M, Visser N, de Gorter DJ, Doorn J, Goumans MJ, de Boer J, ten Dijke P.
    J Bone Miner Res; 2010 Jun 15; 25(6):1208-15. PubMed ID: 19929436
    [Abstract] [Full Text] [Related]

  • 18. Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification.
    Culbert AL, Chakkalakal SA, Theosmy EG, Brennan TA, Kaplan FS, Shore EM.
    Stem Cells; 2014 May 15; 32(5):1289-300. PubMed ID: 24449086
    [Abstract] [Full Text] [Related]

  • 19. Elevated BMP and Mechanical Signaling Through YAP1/RhoA Poises FOP Mesenchymal Progenitors for Osteogenesis.
    Stanley A, Heo SJ, Mauck RL, Mourkioti F, Shore EM.
    J Bone Miner Res; 2019 Oct 15; 34(10):1894-1909. PubMed ID: 31107558
    [Abstract] [Full Text] [Related]

  • 20. Twists in the fibrodysplasia ossificans progressiva story challenge and expand our understanding of BMP biology.
    Collins MT.
    J Clin Invest; 2022 Jun 15; 132(12):. PubMed ID: 35703179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.